212 related articles for article (PubMed ID: 26706028)
21. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
22. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
Kaufhold S; Garbán H; Bonavida B
J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
[TBL] [Abstract][Full Text] [Related]
23. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma.
Luo W; Li S; Peng B; Ye Y; Deng X; Yao K
PLoS One; 2013; 8(2):e56324. PubMed ID: 23424657
[TBL] [Abstract][Full Text] [Related]
24. Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis.
Basati G; Mohammadpour H; Emami Razavi A
J Gastrointest Cancer; 2020 Mar; 51(1):41-47. PubMed ID: 30628031
[TBL] [Abstract][Full Text] [Related]
25. SOX2 Expression in Cervical Intraepithelial Neoplasia Grade 3 (CIN3) and Superficially Invasive (Stage IA1) Squamous Carcinoma of the Cervix.
Stewart CJ; Crook M
Int J Gynecol Pathol; 2016 Nov; 35(6):566-573. PubMed ID: 26886477
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
[TBL] [Abstract][Full Text] [Related]
27. The Stem Cell-associated Transcription Factor SOX2 as a Diagnostic Marker of High-grade Squamous Intraepithelial Lesion of the Uterine Cervix in Comparison With p16 and Ki-67.
Wolsky RJ; Harbour LN; Mirza KM; Montag AG; Gwin K
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):403-410. PubMed ID: 27490766
[TBL] [Abstract][Full Text] [Related]
28. [Expression of SOX2 in cervical intraepithelial neoplasia and cervical cancer and its clinical significance].
Cai CF; Tan GS; Yu Q; Luan F; Yu L; Wang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):128-30. PubMed ID: 25613627
[TBL] [Abstract][Full Text] [Related]
29. Expression analysis of putative stem cell markers in human benign and malignant prostate.
Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
[TBL] [Abstract][Full Text] [Related]
30. Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions.
Xiao L; Song Y; Huang W; Yang S; Fu J; Feng X; Zhou M
Reprod Biol Endocrinol; 2017 Mar; 15(1):14. PubMed ID: 28253866
[TBL] [Abstract][Full Text] [Related]
31. Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
Hou T; Zhang W; Tong C; Kazobinka G; Huang X; Huang Y; Zhang Y
BMC Cancer; 2015 Oct; 15():785. PubMed ID: 26499463
[TBL] [Abstract][Full Text] [Related]
32. Oct4 and Sox2 are overexpressed in human neuroblastoma and inhibited by chemotherapy.
Yang S; Zheng J; Ma Y; Zhu H; Xu T; Dong K; Xiao X
Oncol Rep; 2012 Jul; 28(1):186-92. PubMed ID: 22576801
[TBL] [Abstract][Full Text] [Related]
33. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
34. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B
Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337
[TBL] [Abstract][Full Text] [Related]
35. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.
Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283
[TBL] [Abstract][Full Text] [Related]
36. Low P16
Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
[TBL] [Abstract][Full Text] [Related]
37. OCT4&SOX2-specific cytotoxic T lymphocytes plus programmed cell death protein 1 inhibitor presented with synergistic effect on killing lung cancer stem-like cells in vitro and treating drug-resistant lung cancer mice in vivo.
Zhang X; Hu F; Li C; Zheng X; Zhang B; Wang H; Tao G; Xu J; Zhang Y; Han B
J Cell Physiol; 2019 May; 234(5):6758-6768. PubMed ID: 30382588
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of LAPTM4B-35 in cervical carcinoma: a clinicopathologic study.
Meng F; Luo C; Hu Y; Yin M; Lin M; Lou G; Zhou R
Int J Gynecol Pathol; 2010 Nov; 29(6):587-93. PubMed ID: 20881850
[TBL] [Abstract][Full Text] [Related]
39. SOX2 as a prognostic marker and a potential molecular target in cervical cancer: A meta-analysis.
Yuan D; Wang J; Yan M; Xu Y
Int J Biol Markers; 2021 Dec; 36(4):45-53. PubMed ID: 34719977
[TBL] [Abstract][Full Text] [Related]
40. STAT3 correlates with stem cell-related transcription factors in cervical cancer.
Wang H; Cai HB; Chen LL; Zhao WJ; Li P; Wang ZQ; Li Z
J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):891-897. PubMed ID: 26670442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]